The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (7 analysts) rates it none, with a mean price target of $23. Since the last review it its composite score eased.
Acadia Realty Trust
AKR · the NYSE · USD · Market cap $2.9B · 138 employees
Acadia Realty Trust is an equity real estate investment trust focused on delivering long-term, profitable growth.
FAIL · Does not pass the screenPrice as of 13 Nov 2026Daily close, not a live quote
Screened 2026-11-13 · the tape above runs as of 04:19 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price20.21 USD at the 13 Nov 2026 close
- Our value readOvervalued vs our fair value, as of 13 Nov 2026
- Our regime readMarkup, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans heavily to calls (put/call 0.67)
- Last reviewed13 Nov 2026 (3 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $15.28 to $17.57, base estimate $15.28 (screen dated 2026-11-13).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.67, read 2026-11-14
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Acadia Realty Trust holds its Markup at $20.21. The statistical read favours the buyers, held for 11 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the buyers, held for 11 days |
| Price at the screen | $20.21 |
| Valuation | 73.59 trailing · 48.46 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.13 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 39.71% | Below 33% | Interest-bearing debt is 39.7% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 2.15% | Below 49% | Money owed to the company is 2.1% of assets, under the 49% limit. | Pass |
| Revenue purity | 5.77% | Below 5% | 5.8% of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Acadia Realty Trust's business is in a permissible area, but its interest-bearing debt is about 40% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when AKR's ethical verdict changes
Today AKR does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 13 Nov 2026: it trades above our $15.28 fair value estimate.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. The price runs 32.3% above the base estimate.
Third-party analyst targets: 7 covering, consensus Strong Buy. The average target sits +19% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $15.28, with a range of $15.28 to $17.57, dated to the 2026-11-13 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsPaying Top Dollar For Shrinking Retail Rents
Picture a landlord raising the rent on shops that are already losing customers. Acadia Realty Trust owns street retail in busy US corridors, yet revenue is sliding one percent a year while the shares trade at eighty times forward earnings, far above our fair value of thirteen dollars against the current twenty two.
We pass because nothing in the numbers supports the price. Profit margins sit at eleven percent, return on equity is only four percent, and the market still hands it a strong buy label with a twenty four dollar target. That gap between what the business earns and what investors are asked to pay is simply too wide.
Retail property values move with consumer spending and interest rates, so any slowdown could hit income harder than the high multiple allows. Ethical checks clear, yet the valuation leaves no margin for error.
Analysis, not advice.
| Forward P/E | 48.5xexpensive: the price assumes strong growth ahead |
| Trailing P/E | 73.6xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 0.27 |
| EPS, forward | 0.41 |
| Revenue growth | -2.9%revenue is shrinking |
| Profit margin | 11.1%thin but positive margins |
| Return on equity | 6.0%a modest return on shareholder capital |
| FCF yield | 5.21% |
| Dividend yield | 3.57% |
| Debt to equity | 0.70moderate, manageable leverage |
| Current ratio | 1.31adequate liquidity, worth monitoring |
| Beta | 1.13moves a little more than the market |
| Short interest, float | 0.22% |
| 52-week range | 17.96 - 23.03 |
| Market cap | $2.9B |
| Employees | 138 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeAKR trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (7 analysts) rates it none, with a mean price target of $23. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (7 analysts) rates it none, with a mean price target of $23. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (7 analysts) rates it none, with a mean price target of $23. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (7 analysts) rates it none, with a mean price target of $23. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 3.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (7 analysts) rates it none, with a mean price target of $23. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (7 analysts) rates it none, with a mean price target of $23. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (7 analysts) rates it none, with a mean price target of $23. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (7 analysts) rates it none, with a mean price target of $23. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (7 analysts) rates it none, with a mean price target of $23.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Swedbank Provides EUR 130 Million in Financing to Akropolis Group Yahoo Finance · 10d ago
- Acadia Realty Trust Announces $0.20 Per Share Quarterly Dividend Yahoo Finance · 11d ago
- Acadia Realty Trust (AKR) (Q3 2026) Earnings Call Highlights: Street Portfolio Fuels 10. ... Yahoo Finance · 13d ago
- Acadia Realty: 3 Key Takeaways for Long-Term Investors Yahoo Finance · 13d ago
- Acadia Realty Trust Q3 2026 Earnings Call Summary Yahoo Finance · 13d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $21.79 | -1.9% | · | $981 | -1.9% |
| 2 months | $20.73 | +3.1% | · | $1,031 | +3.1% |
| 3 months | $20.22 | +5.7% | $0.20 | $1,067 | +6.7% |
| 6 months | $19.74 | +8.3% | $0.40 | $1,103 | +10.3% |
| 1 year | $19.14 | +11.7% | $0.80 | $1,158 | +15.8% |
| 2 years | $15.68 | +36.3% | $1.56 | $1,463 | +46.3% |
| 3 years | $12.73 | +67.9% | $2.28 | $1,858 | +85.8% |
| 5 years | $18.36 | +16.4% | $3.63 | $1,362 | +36.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever AKR does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.